GLP-1 Usage Table
The medical conditions for which each GLP-1 medication is indicated
Postcall Staff
April 27, 2026
|
Medication |
Approved Uses |
Dosing Frequency |
Initial Dose |
Maintenance Dose |
Benefits |
|---|---|---|---|---|---|
|
Ozempic |
Type 2 Diabetes |
Once weekly |
0.25 mg |
Up to 1 mg |
Reduces A1C, supports weight loss |
|
Wegovy |
Obesity (BMI ≥30, or BMI ≥27 with at least one weight-related condition) |
Once weekly |
0.25 mg |
Up to 2.4 mg |
Significant weight loss |
|
Victoza |
Type 2 Diabetes, to reduce the risk of major cardiovascular events |
Daily |
0.6 mg |
Up to 1.8 mg |
Lowers cardiovascular risk in addition to managing diabetes |
|
Saxenda |
Obesity (BMI ≥30, or BMI ≥27 with at least one weight-related condition) |
Daily |
0.6 mg |
Up to 3.0 mg |
Promotes weight loss |
|
Mounjaro |
Type 2 Diabetes, Obesity (BMI ≥30, or BMI ≥27 with weight-related comorbidities) |
Weekly |
2.5 mg |
Up to 15 mg |
Lowers blood sugar and body weight |
|
Rybelsus |
Type 2 Diabetes |
Daily |
3 mg |
Up to 14 mg |
Convenient for those who prefer pills |
|
Zepbound |
Type 2 Diabetes, Obesity (BMI ≥30, or BMI ≥27 with weight-related comorbidities) |
Weekly |
2.5 mg |
5-15 mg |
Substantial weight loss over longer periods |
